Ozempic face: what a cosmetic can and cannot do

It is the question I have been asked most often over the past year, and it always comes the same way: "I have lost twenty kilos, I am happy, but my face looks ten years older. What can I use?"

I have to give an uncomfortable answer, and I would rather give it right away: a cosmetic cannot restore lost volume. What a good routine can do is something else, and it is far from insignificant: with this type of skin, the scope for visible improvement is actually greater than usual, because marked dehydration often accompanies the loss of volume. And that, at least, can be visibly improved.

Cover image generated with the support of artificial intelligence.

[INDICE:h2]

What is the so-called Ozempic face?

The name is journalistic, not clinical: it was coined in 2023 by a New York dermatologist and picked up by the international press. It describes the appearance of the face after rapid and substantial weight loss, now common because it is associated with GLP-1 receptor agonist medications, originally developed for type 2 diabetes and widely prescribed for obesity.

The important thing to understand is that the best-documented evidence concerns the weight loss, not the medication. A narrative review published in the Journal of Drugs in Dermatology in May 2026 examined twenty-five years of literature on the effects of rapid weight loss on soft tissues, comparing diet, bariatric surgery, and drug therapies. The most useful conclusion for readers is that the speed and extent of weight loss matter more than the method used to achieve it. In studies of substantial weight loss, the authors describe changes in the architecture of collagen and elastin fibers, reduced fibroblast activity, and thinning of the epidermis and dermis.

In other words: the phenomenon has become common, not new. It was seen after bariatric surgery, following drastic diets, and during periods of illness. The scale has changed, not the mechanism.

Does the medication act directly on the skin?

It is still an open question, and anyone who answers confidently in either direction is going beyond the data. There are hypotheses about the role of dermal white adipose tissue, a metabolically active layer connected to the skin, and the possibility that the GLP-1 signal influences its behavior. But prospective human studies capable of separating the drug’s direct effect from that of weight loss are lacking.

Presenting “GLP-1 collagen destruction” as established fact would be premature. Dismissing what happens to the tissues during substantial weight loss as irrelevant would be equally wrong.

Why the face changes

The face is not a surface: it is a layered structure, and beneath the skin are distinct fat compartments, each with its own geometry. They are what keep the cheeks lifted and support the contours of the face.

When body fat decreases quickly, those compartments empty along with all the others. The result is twofold: the skin has to cover a smaller volume, and the shadow beneath the cheekbone becomes deeper. This creates the impression of a face that suddenly looks more tired, even in someone who is objectively healthier than before.

There is also an elastic component: if the skin has already experienced an age-related reduction in collagen and elastin, it retracts less, and the loss of support is more clearly visible. This is why, at thirty, the same amount of weight loss is generally much less noticeable than at fifty. Age, genetics, baseline skin quality, sun exposure, menopause, the amount of weight lost, nutrition, and muscle mass make the outcome highly variable from person to person: there is no one-size-fits-all destiny.

“It isn’t the skin that has worsened. It’s the structure beneath the skin that has diminished, and the skin is simply revealing what it finds underneath.”

Where the cosmetic boundary lies

Deep volume is located in an area that a product applied to the skin cannot reach, and restoring it is, by definition, a medical procedure. This is also the regulatory boundary: Regulation (EC) No 1223/2009 defines cosmetics as products intended to alter the appearance of the external surfaces of the body, protect them, or keep them in good condition, and Regulation (EU) No 655/2013 does not allow claims beyond that.

When you see a cream advertised as having a "volumizing effect," it's referring to a surface-tensing effect: films that smooth, hydration that plumps the upper layers, and optical effects that reduce shadowing. These effects are real, immediate, and pleasant. And on a face that has just lost volume, they're more noticeable than on another face. They simply last as long as the product remains on the skin, and should be described for what they are.

The three interventions that really change the appearance

This is where the answer stops being disappointing, because a well-designed routine delivers more than average for this condition.

1. Restore hydration, which delivers the fastest result

With rapid weight loss, dietary intake, systemic hydration, and often the balance of skin lipids change. The skin becomes dehydrated, dull, and rough: and dehydrated skin accentuates every shadow and line. Correcting it doesn't rebuild volume, but it visibly changes how the face looks, generally within two or three weeks.

That's why I work with hyaluronic acid in different molecular weights for this type of skin: low-molecular-weight hyaluronic acid works on hydrating the deeper layers of the epidermis, while high-molecular-weight hyaluronic acid retains water on the surface and restores immediate plumpness.

2. Protect the elastic component that remains

Lost elasticity doesn't come back, but you can stop wearing it down. Daily sun protection, antioxidants, consistency: that's the logic behind collagen banking, and it makes even more sense here, because the skin is already working with less support and doesn't need to lose quality as well.

3. Work on texture and nourishment

Evenness of skin tone, radiance, surface firmness, and adequate lipid content in skin that has lost some. These are the realistic goals, and they're what people describe as "I look less tired"-which is ultimately the sentence they wanted to be able to say from the beginning.

One thing that doesn't concern cosmetics but needs to be said: if you're undergoing treatment, any assessment of the medication, the rate of weight loss, and protein intake should be made by the doctor who prescribed it. Do not stop or modify anything for an aesthetic reason without discussing it with them. And if the loss of volume really bothers you, the person to consult is an aesthetic doctor, not a cream.

And your hair? Here, the signal is more concrete

This is the part of the conversation growing fastest, and unlike facial volume, it is backed by serious numbers.

In February 2026, a multicenter study published in JAAD International analyzed electronic health records from 67 U.S. healthcare facilities: after matching for age, sex, ethnicity, body mass index, and presence of diabetes, each cohort included nearly 548,000 patients. At twelve months, people taking GLP-1 agonists showed higher odds of nonscarring alopecia (telogen effluvium and androgenetic alopecia) than the controls.

In July 2026, a study published in the BMJ found the same association in adults with type 2 diabetes, using data from the University of Pennsylvania: a 37% higher risk of alopecia than with SGLT-2 inhibitors (6.91 versus 5.04 cases per 1,000 person-years) and 68% higher than with DPP-4 inhibitors. The same authors emphasize that the absolute risk remains low.

Pay attention to the logical leap, because this is where marketing will slip: association does not mean causation. Rapid weight loss, insufficient intake of protein, iron, or zinc, and metabolic stress are known causes of telogen effluvium, diffuse and generally temporary hair loss. Observational studies cannot completely separate these factors from any potential drug-specific effect.

The practical consequence is that a shampoo, scalp serum, or device is not the answer. Noticeable hair loss requires identifying its cause, especially if it persists for more than a few months, appears in patches, or is accompanied by other symptoms. The first thing to do is not buy a product "for people who use GLP-1"; it is to discuss it with the doctor overseeing the treatment and have nutritional status checked.

Is GLP-1 beauty a category or a vocabulary?

Within a few months, the conversation has shifted from correction to prevention: firming creams, cosmetics that promise a volumizing effect, more sophisticated body care, scalp products, and devices specifically aimed at people undergoing treatment. Body care, in particular, is adopting the vocabulary of facial actives (retinoids, peptides, acids, ceramides), because the arms, abdomen, and thighs make changes visible across much larger surfaces.

The question behind it is valid: how do you support the skin as the body changes? The risk is looking for a cosmetic answer at every level of the problem, including those where one cannot exist.

When I read a claim in this category, I ask myself four questions, and they are the same ones I recommend that buyers ask themselves.

1. Was the product tested specifically during GLP-1 therapy? A generic test on hydration or wrinkles does not demonstrate the prevention of volume loss during weight loss. If the claim refers to that condition, the study should have been conducted on those people.
2. What was measured? Hydration, elasticity, wrinkles, dermal density, and facial volume are different parameters. An improvement in the first proves nothing about the others.
3. Does the data concern the ingredient or the finished product? An in vitro result on a single active ingredient describes a possible mechanism. It does not demonstrate that the complete formula does the same thing on real skin.
4. Does the language confuse cosmetics with medicine? "Filler in a bottle" is a commercial metaphor, not a biological equivalent.

I would add why before-and-after photographs alone are never enough for me: lighting, angle, expression, and distance from the camera alter the perception of volume more than any cream could.

Why this conversation needs to happen at the counter

It strikes me that someone who has significantly improved their health should find themselves considering their condition worse. And that is precisely why I believe the right response is not to allude to restoring volume, which a cosmetic product cannot provide, but to clearly explain what it can improve. It is the usual mechanism: when a new and urgent demand arises, the offering arrives before the evidence.

When developing a formula, the decisive step is not choosing the trendy word, but determining which parameter the product can realistically improve and building the test around it. On this subject, I distinguish three levels: the skin's surface, the dermal structure, and the volume of deep tissues. A cosmetic product works well on the first and, with appropriate testing, on certain aspects of the second. Regarding the third, every claim requires the utmost caution.

My answer is more boring, and it works: distinguish what can be changed from what cannot, build a routine around three precise goals, and look at your face again after a month. But this is a conversation that requires someone to look you in the face and ask what you are using now, which is why we chose pharmacies and parapharmacies as our channel: you can find our formulas in our partner pharmacies and parapharmacies.